妊娠期糖尿病产妇产时血糖管理:一项随机对照试验
该随机对照试验将76例妊娠期糖尿病(GDM)经阴道分娩孕妇分为严格产时血糖管理组与宽松管理组,每组38例。主要结局首次新生儿血糖两组相似(53 mg/dL vs 58 mg/dL,均差-4.18,95%CI -12.66至4.29)。作者认为研究支持提高产时母体血糖上限阈值并减少产时血糖评估频率。
要点
- 严格产时血糖管理未改善首次新生儿血糖(53 mg/dL vs 58 mg/dL,均差-4.18,95%CI -12.66至4.29)。
- 严格组新生儿生后24小时内平均血糖较低(54 mg/dL vs 58 mg/dL,均差-3.39,95%CI -7.07至0.29)。
- 作者认为研究支持提高产时母体血糖上限阈值并减少产时血糖评估频率。
核心结论
- 与宽松管理相比,GDM产妇产时严格血糖管理未带来更好的首次新生儿血糖浓度,且与生后24小时内新生儿平均血糖较低相关。
- 作者认为本研究支持提高GDM产妇产时母体血糖上限阈值并减少产时血糖评估频率。
研究设计与样本
- 随机对照试验,纳入单胎妊娠且患GDM并尝试经阴道分娩的孕妇。
- 2016年2月至2018年4月共随机76例,严格组38例、宽松组38例,全部纳入分析。
- 严格组每小时测血糖,母体血糖低于60 mg/dL或高于100 mg/dL时治疗;宽松组每4小时测血糖,母体血糖低于60 mg/dL或高于120 mg/dL时治疗。
- 主要结局为首次新生儿血糖水平;总样本量74例可提供80%把握度检出组间10 mg/dL均差。
- 两组基线产科变量可比,平均孕周均为39周;产前每组约三分之二孕妇接受药物治疗(几乎均为胰岛素)。
主要发现
- 主要结局首次新生儿血糖两组相似:严格组53 mg/dL vs 宽松组58 mg/dL,均差-4.18,95%CI -12.66至4.29。
- 生后24小时内平均新生儿血糖严格组低于宽松组:54 mg/dL vs 58 mg/dL,均差-3.39,95%CI -7.07至0.29。
- 其他次要结局两组相似。
临床怎么用
- 作者认为本研究支持提高GDM产妇产时母体血糖上限阈值并减少产时血糖评估频率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effect of tight compared with liberalized intrapartum maternal glucose management on neonatal hypoglycemia risk in pregnancies complicated by gestational diabetes mellitus (GDM). METHODS: This was a randomized controlled trial of women with singleton gestations and GDM attempting vaginal delivery. After written informed consent, women were randomly allocated to one of two intrapartum maternal glucose management protocols: tight control (glucose measurements hourly and treatment for maternal glucose levels lower than 60 mg/dL or greater than 100 mg/dL) or liberalized control (glucose measurements every 4 hours and treatment for maternal glucose levels lower than 60 mg/dL or greater than 120 mg/dL). The primary outcome was the first neonatal blood glucose level; a total sample size of 74 was necessary to have 80% power to detect a mean difference of 10 mg/dL between groups. Secondary outcomes included neonatal blood glucose concentrations within the first 24 hours of life, number of glucose treatments (intravenous or oral) received to treat neonatal hypoglycemia, neonatal intensive care unit admission, and neonatal hyperbilirubinemia. RESULTS: From February 2016 to April 2018, 76 women were randomized (38 in each group), and all were included in the analysis. Baseline characteristics of the two groups were comparable for all relevant obstetric variables; mean gestational age was 39 weeks in both groups. Antepartum, two thirds of women in each group were treated medically (almost exclusively with insulin). The primary outcome was similar between the tight and liberalized control groups: 53 mg/dL vs 58 mg/dL, mean difference -4.18, 95% CI -12.66 to 4.29. However, mean neonatal glucose level within the first 24 hours of life was lower in the tight control group: 54 mg/dL vs 58 mg/dL, mean difference -3.39, 95% CI -7.07 to 0.29. Other secondary outcomes were similar between groups. CONCLUSION: A protocol aimed at tight maternal glucose management in labor compared with liberalized management for women with GDM did not result in better initial neonatal glucose concentrations and was associated with lower mean neonatal blood glucose levels in the first 24 hours of life. This study supports raising the upper threshold for intrapartum maternal glucose and decreasing the frequency of intrapartum glucose assessment for women with GDM. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02596932.
引用
- Hamel MS, Kanno LM, Has P, et al. Intrapartum Glucose Management in Women With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstet Gynecol. 2019. PMID: 31135731. doi:10.1097/AOG.0000000000003257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。